Clinical trials rely on precision, speed, and safety — and the design of Randomization and Trial Supply Management (RTSM) systems is central to delivering on these demands. An approach built around real-world user personas, such as sponsors, site coordinators, supply managers, and patients, ensures that workflows reflect how people actually work rather than idealized assumptions. Clear navigation, role-specific safeguards, and embedded guidance help reduce protocol deviations and enhance patient safety, while streamlined processes support faster study startup and timely data locks. The outcome is stronger data integrity, fewer manual interventions, and meaningful gains in operational efficiency.
For organizations aiming to elevate trial performance, UX-driven RTSM design is not just a usability improvement; it is a strategic advantage that accelerates the delivery of safe, effective therapies to market. Elosity, an RTSM platform built on user centricity and patient safety, turns complex clinical workflows into simple, intuitive experiences for sponsors, sites, depots, and patients. Through persona-based design and continuous usability testing with real stakeholders, Elosity drives measurable improvements in trial speed, data accuracy, protocol adherence, and overall user satisfaction, ultimately enabling more predictable and successful development programs. This paper explores how Elosity strengthens everyday clinical operations and enhances trial reliability by placing exceptional user experience (UX) at the core of its RTSM architecture.
